Showing 13 results for Morbid Obesity
Seyed Hossein Hosseini, Ahmad Izadpanah, Seyed Vahid Hosseini, Hossein Shabahang, Elaheh Ashrafi, Ali Reza Safarpour, Abbas Rezaianzadeh, Zahra Zabangirfard,
Volume 3, Issue 1 (2-2014)
Abstract
Background
Since morbid obesity is known as a major cause of psychosocial problems beside its common adverse effects like cardiovascular and metabolic diseases, a lot of researches have been performed to find an effective treatment including surgery. Surgical methods were improved by invention of minimal invasive surgeries. Laparascopic Sleeve Gastrectomy (LSG) and Laparascopic Adjustable Gastric Banding (LAGB) are the methods which have become common in most of developed countries.
Objectives
Due to cultural, economic and social differences between our country and developed countries, we have designed this research to compare the efficacy and complication of these two methods six months after operation in hospitals affiliated to Shiraz University of Medical Sciences.
Patients and Methods
Documents of patients operated with one of these two methods were reviewed, and necessary information was inserted in prepared forms. We called patients if further information was needed. Then this data was analyzed with Chi Square 2Sample Independent T- test and Paired T Test by SPSS 16 software.
Results
Seventy patients were operated with LSG and 25 with LAGB. The Mean weight of LSG group was 120.73 and 120 for LAGB. The Mean weight loss in LSG was 29.99 and 19.60 in LAGB. There was no statistically significant difference regarding early complications between the two methods; although, long term complications such as gastric stenosis and band displacement were statistically more in LAGB.
Conclusions
It seems that both LSG and LAGB are efficient in weight loss but LSG can lead to more weight loss, better correction of blood pressure and less long term complications.
Mohsen Mahmoudieh, Behrouz Keleidari, Gholamreza Mohajeri, Masoud Sayadi Shahraki, Shervin Badihian, Mahsa Gharzi, Samira Davashi,
Volume 3, Issue 3 (8-2014)
Abstract
Introduction
AGB (adjastable gastric bandin) is the most common method for treatment of obesity which is performed all around the world and provides a significant weight loss for patients. Despite all its benefits as a method that requires the least intervention, complications such as gastric prolapse, stoma stenosis and migration band may also occur. These complications rarely result in mortality, but usually the only treatment for them is surgery.
Case Presentation
We report a rare complication of this procedure which had caused small intestine obstruction.
Conclusions
Small intestine obstruction caused by band migration is a very rare complication and must be considered as a differential diagnosis in patients with small intestine obstruction symptoms. Therefore correct surgical methods must be adopted for its treatment so that it may not let the surgeon get misled during the operation and let him do the treatment correctly.
Mahmoud Arshad, Nasrin Rezvandoost, Abdolreza Pazouki, Sajedeh Riazi, Maryam Aghababa Rangraz, Somayyeh Mokhber,
Volume 5, Issue 2 (6-2016)
Abstract
Background
Considering the importance of providing vitamins and minerals in body health, it obviously seems to be necessary to assess the deficiencies of these nutrients in obese patients.
Objectives
The present study aimed to evaluate the level of hemoglobin, ferritin, and vitamin B12 in a sample of Iranian population with morbid obesity.
Patients and Methods
This cross-sectional study was conducted on 1252 consecutive patients with morbid obesity referred to obesity clinic at Rasoul-e-Akram hospital from 2009 to 2015 in Tehran, IR Iran. Morbid obesity was defined as body mass index (BMI) equal to or higher than 40 kg/m2. Serum hemoglobin level (gr/dL) was measured using the cyan methemoglobin method. Serum ferritin level (ng/mL) can be measured by the human ferritin enzyme immunoassay test. Also, serum vitamin B12 concentration (pg/mL) was measured using the solid-phase, competitive chemiluminescent enzyme immunoassay method.
Results
Overall, 1252 patients with morbid obesity were included in the study. The mean age of participants was 39.77 ± 10.84 years (ranged 10 to 70 years) and 80.3% of them were female. The mean body weight was 126.75 ± 21.58 kg and the mean BMI was also 46.99 ± 5.87 kg/m2. In result, 9.8% were anemic according to the low value of hemoglobin level, 46.6% had ferritin lower than the normal range and the average serum level of vitamin B12 was lower than the normal value in 21.1%. By applying the Pearson’s correlation test, a positive association was found between BMI value and the level of hemoglobin (r = 0.074, P = 0.009).
Conclusions
Morbid obesity may result in two important hematologic and metabolic changes including increased hemoglobin level and reduced vitamin B12 level. Since, vitamin B12 has vital role in the body, providing adequate vitamin B12 is essential in these patients even by using vitamin supplements. Also, regular screening of the level of hematologic markers in these patients is strongly recommended.
Amir Hossein Faghihi, Somayyeh Mokhber, Arezou Hashemzadeh, Pejman Mansouri, Abdolreza Pazouki,
Volume 5, Issue 4 (10-2016)
Abstract
Background
Obesity, a major risk factor for fatty liver disease, is increasing worldwide. Morbid obese patients have a higher prevalence of fatty liver disease in addition to more severe complications, and high prevalence of abnormal liver function tests (LFTs). The aim of this study is to determine the pattern of LFT and liver ultrasonography of morbid obese Iranian patients undergoing bariatric surgery.
Methods
The study population included 308 morbid obese patients who were candidates for Laparoscopic Roux-en-Y Gastric Bypass surgery. Body mass index (BMI), age, gender, weight, height, blood tests including alanine transaminase (ALT), aspartate transaminase (AST), direct bilirubin (Bil D), total bilirubin (Bil T), and liver ultrasound reports were recorded for all of the patients. Patients with alcohol intake or hepatitis or human immunodeficiency virus (HIV) were excluded from the study. The data were entered and analyzed using SPSS-16. The chi-square, ANOVA and Independent-sample t- test used in the study analysis.
Results
Data analyses showed that alkaline phosphatase (ALKP) is the most elevated serum enzyme in morbid obese patients 26 (87.6%). ALT, AST, bilirubin total and bilirubin direct were more than upper normal range in 70 (24.1%), 80 (26%), 2 (1.5%) and 15 (11.4%) in all patients, respectively. Ultrasonography of the liver showed that fatty liver disease occurred in approximately 280 (91%) of our patients. In our study, the only liver enzyme that had significant difference with fatty liver and normal groups was AST (P: 0.027). The patients were divided into three groups on the basis of the BMI: BMI of 35 - 40 kg/m2, 40 - 50 kg/m2, and above 50 kg/m2. There is not any significant difference between the mean of ALKP, ALT, AST, bilirubin (direct and total) serum level and fatty liver in these three groups.
Conclusions
The prevalence of abnormal LFTs in Iranian morbid obese patients is in high status especially the level of ALKP. Liver ultrasonography has high sensitivity for the fatty liver in morbid obese patients but LFTs rise only in few patients with fatty liver.
Parisa Janmohammadi, Gholamreza Mohammadi-Farsani, Hana Arghavani, Mahmoud Arshad, Tayebeh Mokhber,
Volume 6, Issue 1 (2-2017)
Abstract
Introduction
Klinefelter syndrome is a disorder of chromosomes in which common karyotype is (47XXY). Hypogonadism, gynecomastia and azoospermia could be detected in this syndrome. Decreased basal metabolic rate and interest in activities, loss of muscle mass, weight gain, the deficiency of sex hormone and mood changes cause obesity which cause morb obese in this case.
Case Presentation
A 34-year-old morbid obese (BMI = 60.40) male was come to the Laporoscopy research center of Iran University of Medical science at 26 January 2016. He was diagnosed as Klinefelter syndrome by genetic testing (47XXY karyotype). He reported suffering from knee cellulitis, headache, low back pain and varices. His nutrition habits was fast eating, Sweet eating and Snack eating. The beginning of his obesity was in his childhood. The best treatment for his obesity and its side-effects is altering in his life style, low calorie diet. Finally, if these methodes fail to lose weigth, bariatric surgery is suggested.
Conclusions
In morbid obese patients apporopriate diet, change in calorie intake and life style should be considered as a first line of treatment and finally, surgery may be an option to treat obesity. These two methodes can often help reduce the risk of other diseases (e.g., diabetes, heart disease, and sleep apnea) that are associated with severe obesity.
Volume 6, Issue 2 (5-2017)
Abstract
Introduction
After cessation of smoking, the best way to prevent health-threatening conditions is to treatment of obesity. Also, obesity treatment, cause alleviation or cure of other diseases. Bariatric surgery in selected obese patients is the best option for preventing health-threatening conditions. Despite the health benefits, this method of treatment -just like other surgical procedures- may be associated with various side effects.
Case Presentation
A 55-year-old female with BMI of 46.5 underwent laparoscopic Omega Gastric bypass surgery. She was admitted due to dyspnea and pulmonary embolism 14 days later. In conducted surveys, platelet count was less than 25,000. In multiple assessments, no cause found for the thrombocytopenia. Corticosteroids prescribed for her with the diagnosis of ITP; which fully responded to treatment.
Conclusions
Thrombocytopenia is a rare complication of gastric bypass surgery. Managements include rule out of other causes of thrombocytopenia and medical treatment.
Mahsa Hatami, Gholamreza Mohammadi Farsani,
Volume 6, Issue 3 (8-2017)
Abstract
Background
Migraine is a common and chronic neuro-inflammatory disease with progressive and episodic headache manifestation that leads to considerable disability. Many studies recognized that obesity is a risk factor for progression of migraine. Furthermore, both migraine and obesity is highly prevalent and important risk factors of chronic cardiovascular disease, stroke, and other inflammatory disease. Thus, it is very important if weight loss could alleviate the migraine headache and its related comorbidities.
Aim
The present review article was conducted to assess the potential effect of Bariatric surgery on improvement of migraine headaches in morbid obese patients.
Search Strategy
Scopus, PubMed and web of science electronic database were systematically searched with key words of “Bariatric surgery”, “gastric Bypass”; “Morbid Obesity” and “Migraine headache” for interventional studies investigated the impact of Bariatric surgery on migraine headache.
Results
The findings suggest significant improvement in headache frequency, duration, migraine-induced discomfort and migraine derived symptoms (nausea, phono and photophobia and) occurs as early as 3 months after bariatric surgery. Moreover, patients who had higher weight loss were more likely to experience a 50% or higher reduction in headache frequency, duration and severity.
Conclusions
The entire evidences suggest patients with indications of bariatric surgery will benefit from the improvements in the Migraine headache after surgery. However, it remains unclear whether Bariatric-induced endocrine, gut-brain axis alterations, or reduction in adipokine contribute to migraine improvement, so further studies are needed to confirm and clarify these findings.
Volume 7, Issue 1 (2-2018)
Abstract
Background
Obesity is widely considered as an important risk factor for impaired physical function and disability. Even mild to moderate weight loss has been shown to improve physical function. This study aimed to evaluate the effect of Roux-en-y gastric bypass (RYGB) surgery on some fitness parameters in women with morbid obesity.
Methods
Seventy two women with morbid obesity body were included in this study. They were followed for six months after RYGB surgery. Some fitness parameters including body composition (using bioelectrical impedance), muscular strength (leg press in lower limb and hand power grip in upper limb) and six minute walk test (6MWT) were evaluated before surgery and that at intervals of 1, 3 and 6 months after surgery. One way repeated measure ANOVA was applied to determine the data changes during the follow up period.
Results
BMI and body weight of all samples declined constantly during 6 months follow up after surgery. Also, by the end of the study, the body fat percent decreased from 48.2 (3) to 36.4 (4) (P < 0.05). The distance which patients paced in 6MWT increased 22% during 6 months follow up (P < 0.0001). Although handgrip and leg press of the participants decreased following the gastric bypass surgery, the power grip/weight ratio and leg press /weight ratio improved significantly through the study (P < 0.0001).
Conclusions
RYGB surgery may positively affect fitness parameters in morbid obese women. The endurance capacity, body composition and even muscle strength seem to be enhanced after gastric bypass surgery.
Mahsa Hatami, Abdolreza Pazouki, Ali Kabir,
Volume 8, Issue 2 (12-2019)
Abstract
Background: Vitamin D3 deficiency is associated with insulin resistance and metabolic syndrome. Although, the evidence was not conclusive. The aim of this study is to investigate the relationship between serum 25-hydroxy vitamin D3 (25(OH) D3) levels with some adiposity and metabolic indices related to metabolic syndrome.
Material and Methods: In this cross-sectional study, the anthropometric, body composition information, the clinical laboratory tests including fasting blood sugar (FBS), insulin, lipid profile, liver enzymes, and serum 25(OH) D3 of 3750 patients with morbid obesity are extracted from Iran National Obesity Surgery Database. HOMA-IR and QUICKI were computed based on the standard formula. Associations were tested using analysis of variance and Kruskal–Wallis tests.
Results: Approximately 69% of patients with morbid obesity had sub-optimal vitamin D3 levels (<20 ng/mL). An inverse significant relationship between serum 25(OH) D3 and body weight, body fat percentage, waist, and hip circumstance was observed (P-Value <0.05 for all). Low serum 25(OH) D3 levels are significantly associated with higher FBS and A1C, dyslipidemia (higher LDL and TG), and also the elevated level of liver function enzymes (P-Value <0.05 for all). Moreover, the patient with the higher serum 25(OH) D3 had a lower level of HOMA-IR and higher insulin sensitivity (QUICKI index); although this association was not statistically significant.
Conclusion: Vitamin D3 deficiency has been associated with adiposity, impaired glucose metabolism, and metabolic disorders related to insulin resistance. Thus, vitamin D3 supplementation could be a potential approach in treatment or decrease the metabolic complication of obesity before and after bariatric surgery.
Alireza Khalaj, Seyed Rouhollah Miri,
Volume 9, Issue 1 (5-2020)
Abstract
Background: Obesity is the most common human metabolic disorder that causes many complications for patients worldwide. On the other hand, Sleeve Gastrectomy is one of the bariatric surgeries that are used by surgeons in morbid obese patients to treat obesity. The aim of this study was to survey on results of Sleeve gastrectomy and its subsequent complications among Iranian patients.
Methods: This is a case series study in which data of 92 morbid obese patients were gathered. Patients were followed up at intervals of 1.5, 3, 6, 12, and 18 months after operation. History of post-operative complications, appetite and satisfaction were taken from patients, physical examination was performed as well as measuring weight and BMI in follow-up visits. Ultrasonography was performed in 6, 12 and 18 months after the surgery for assessing gallbladder.
Results: Mean BMI (body mass index) was 45.43 (± 8.41) kg/m2 in patients. Mean BMI reduction was respectively 4.5 (±1.12), 9.03 (±2.44), 13.45 (±3.45), 17.57 (±4.66), 19.82 (±5.78), 17.57 (±4.66) and 19.82 (±5.78) kg/m2 at 1.5, 3, 6, 12, and 18 months after operation, respectively. Mean weight loss was 71.5% 18 months after operation.
Conclusions: Current study reveals that Sleeve Gastrectomy is an effective method of bariatric surgery in which patients encounter a small number of side effects, and, also, is highly recommended for morbid obese patients.
Seyedhadi Mirhashemi, Maryam Taherkhani, Mohammad Amin Shahrbaf, Ebrahim Afzali,
Volume 9, Issue 1 (5-2020)
Abstract
Background and Aims: Cardiac remodeling and functions are affected after laparoscopic sleeve gastrectomy (LSG); although, the degree of the LSG impression on cardiac function is unclear. The purpose of this study was to determine the effect of LSG on echocardiographic factors in morbidly obese patients.
Methods: In this prospective study, patients with morbid obesity who underwent LSG in Loghman Hakim Hospital, Tehran, Iran in 2017 were evaluated. Echocardiographic parameters such as ejection fraction (EF), left ventricle (LV) diastolic function, LV mass, LV mass index, epicardial fat (EPF), and valvular heart disease including mitral regurgitation (MR), mitral stenosis (MS), aortic regurgitation (AR) and aortic stenosis (AS) were evaluated before and after LSG. All of the data were entered into SPSS software and were analyzed by statistical tests. P values of less than 0.05 was considered significant.
Results: Ninty (90) patients were enrolled in this study. The EF (P=0.012), LV diastolic function (P=0.0001), valvular heart disease (P=0.0001), and LV mass (P=0.002) were significantly improved after LSG. The EPF and LV mass index had no significant difference before and after surgery (P > 0.05).
Conclusion: LSG would have significant effects on echocardiographic factors and cardiac remodeling in patients with morbid obesity.
Fateme Jesmi, Sara Akbarnejad, Mohadeseh Pishgahroudsari, Foolad Eghbali, Abdolreza Pazouki, Fatemeh Sadat Hosseini-Baharanchi,
Volume 9, Issue 1 (5-2020)
Abstract
In this study, we aimed to evaluate the effect of bariatric surgery on constipation followed by the surgery.
This prospective cohort study included 237 patients with morbid obesity, who were candidate for Laparoscopic Roux-en-Y Gastric Bypass (RYGB), and One-Anastomosis Gastric Bypass (OAGB) in Obesiyt Clinic of Rasoul Akram Hospital, Tehran, Iran, 2012-2014. The severity of constipation was measured by Wexner Constipation Score (WCS) before and three months after the surgery. Paired t-test, Mc Nemar test, and logistic regression were applied for the analyses. Mean age and BMI of the 237 patients were 31.59±5.92 years and46.59±5.81kg/m2, respectively. Mean WCS decreased significantly in OAGB group (3.1±4.27 vs. 4.72±4.81, P=0.003), while the reduction in WCS mean score was not significant in RYGB group (4.5±4.73 vs. 4.63±5.19, P=0.793). The proportion of constipation reduced (48/103 vs. 32/103) significantly in OAGB group (P=0.002). Conversely, the decrease in this proportion (from 58/134 to 57/134) was not significant in RYGB group (P=0.06). Considering the confounding role of diet and supplementary intake of the patients, the results of this study showed that the frequency of constipation reduced in morbidly obese patients undergoing obesity surgery and postoperative nutritional recommendations. The comparison between techniques showed that OAGB reduced the constipation score and proportion, while this decrease was not significant in RYGB.
Dr Mahsa Hatami, Dr Hastimansooreh Ansar, Dr Saeed Khajavi, Dr Gholamreza Mohammadi-Farsani,
Volume 10, Issue 1 (6-2021)
Abstract
Background: An enlarged liver, which is resulted from fatty liver and/or steatohepatitis, makes difficulties in gastric bypass surgery procedure and increases the risk of liver laceration. omega-3 polyunsaturated fatty acids (ω-3 PUFAs) recently have been suggested as a potential intervention to reduce liver inflammation and volume. This review aimed to provide a comprehensive overview of the recent advances on fish oil/ ω-3 PUFAs supplementation to reduce the liver volume proceeding to bariatric surgery.
Methods: This review summarizes studies that were investigated the influence of fish oil/omega-3 PUFA in the liver volume of bariatric surgery candidates. Scopus and PubMed databases were systematically searched up to May 2021, for studies providing knowledge relating to the effects of omega-3 and/or fish oil supplementation on liver size, fatty liver, or steatohepatitis.
Results: Most of the randomized controlled trials showed that ω-3 PUFA supplementation, mostly due to its anti-inflammatory and antioxidative properties, is a practical and effective treatment for fatty liver, and to decrease ALT, AST, and GGT. Omega-3 fatty acids as important regulators of hepatic gene transcription can reduce hepatic steatosis and inflammation markers, also improve insulin sensitivity. As well, the access to the gastroesophageal junction was reported as simple.
Conclusion: The collective data suggest that preoperative fish oil ω-3 PUFA supplementation could be an effective approach in improving liver function and decrease liver volume before bariatric surgery. Although, well-designed randomized clinical trials are needed to confirm these results and determine a clear protocol of supplementation regarding the optimal dose and duration before surgery.